SARS-CoV-2 neutralizing antibody therapies: an early retrospective cohort study of 26 hospitalized patients treated with bamlanivimab or casirivimab/imdevimab

OBJECTIVES: In this early retrospective cohort study, a total of 26 patients with SARS-CoV-2 were treated with bamlanivimab or casirivimab/imdevimab, and the reduction of the viral load associated with the developed clinical symptoms was analyzed. METHODS: Patients in the intervention groups receive...

Descripción completa

Detalles Bibliográficos
Autores principales: Heller, Martin, Henrici, Clara, Büttner, Judith, Leube, Sebastian, Treske, Isabelle, Pospischil, Petra, Doll, Michael, Schanz, Ilka, Hallier, Agnes, Herrmann, Eva, Schmidt, Michael, Sarrazin, Christoph
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9859643/
https://www.ncbi.nlm.nih.gov/pubmed/36690138
http://dx.doi.org/10.1016/j.ijid.2023.01.012

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9859643/
https://www.ncbi.nlm.nih.gov/pubmed/36690138
http://dx.doi.org/10.1016/j.ijid.2023.01.012

Ejemplares similares